Custom Antibody Market Research Report – Forecast till 2027

Custom Antibody Market: By Service (Antibody Development), Source (Mice, Others), Research Area (Oncology, Neurobiology), Type (Monoclonal Antibodies, Polyclonal Antibodies), End Users (Biotechnology Companies) — Forecast till 2027

ID: MRFR/HC/5597-HCR | February 2021 | Region: Global | 85 pages

Custom Antibody Market Scenario:
The Custom Antibody Market is expected to register a growth of significant CAGR 9.6% during the forecast period (2018–2023).

Custom antibody provides high specificity and selectivity, these antibodies are easy to produce as compared to other antibodies and are hence the preferred choice in all types of research studies. Factors such as increasing research activity in life sciences industry along with increasing associations between industry and academic centers is driving the growth of the custom antibody market. The advantage of custom antibody is that it accomplishes well in a qualitative or quantitative immunodetection method. The quality of catalog antibodies is also an area of concern in this market, and henceforth end users prefer custom-made antibodies.

Segmentation:
The Custom Antibody Market has been segmented on the basis of service, source, type, research area and end users.

On the basis of service, the market has been classified as antibody development, antibody production & purification, antibody fragmentation & labeling. The antibody development is segmented in to antibody characterization, antigen preparation, immunization & hybridoma production.

On the basis of source, the market has been classified as mice, rabbits, human beings and others.

On the basis of type, the market has been classified as monoclonal antibodies, polyclonal antibodies, recombinant antibodies, others.

On the basis of research area, the market has been classified as oncology, infectious diseases, immunology, neurobiology, stem cells, cardiovascular diseases, other research areas

On the basis of end users, the market has been classified as pharmaceutical & biotechnology companies, hospitals and clinics, academic & research institutes, contract research organizations.

On the basis of region, the market is segmented into the Americas, Europe, Asia-Pacific, and the Middle East and Africa. The Americas has been further segmented into North America and South America, with the North American market divided into the US and Canada.

The European custom antibody market has been segmented into Western Europe and Eastern Europe. Western Europe has further been classified as Germany, France, the UK, Italy, Spain, and the rest of Western Europe.

The custom antibody market in Asia-Pacific has been segmented into Japan, China, India, South Korea, Australia, and the rest of Asia-Pacific. The custom antibody market in the Middle East and Africa has been segmented into the Middle East and Africa.

Regional Market Summary

Global Custom Antibody Market Share, by Region, 2017 (%)

Source: MRFR Analysis

In the custom antibody market, North America is anticipated to account for largest market share due to the early adoption of advanced medical technologies, continuous development by companies operating into disease treatment. The largest market share is credited to the increasing focus of researchers on high-quality antibodies for reproducibility, which can be hampered by using commercially available antibodies.
The European market is expected to hold the second largest market share. Factors such as a rise in research expenses, advancement of technology, the decline in human health, and the necessity for innovative and effective therapies boost the growth of the market in this region. According to Capra Science, a European company specialized in custom antibody production, llama-derived nanobodies might find therapeutic application in Parkinson’s disease.

Whereas the Asia-Pacific region is projected to be the fastest growing segment experience in the near future due to the growing therapeutic industry in India and China, also the increasing funds in life science research by the government organizations of these countries are aspects driving the growth of the Asia-Pacific market. Similarly, the increasing research in genomics and proteomics, growing investments by pharmaceutical companies, rising awareness about personalized therapeutics, and growing research activities in the field of mAb-based therapeutics are boosting the growth of this custom antibody market in Asia-Pacific region.

The market in the Middle East & Africa is expected to account for the smallest share of the global custom antibody market due to an underdeveloped healthcare sector, the dearth of technical knowledge, and poor medical facilities.

Key Players:
Some of the key players in the global custom antibody market are Thermo Fisher Scientific Inc., Genscript, Abcam PLC, Merck Group, Bio-Rad Laboratories, Inc., Cell Signaling Technology, Inc., Agilent Technologies, Inc., Biolegend, Inc., Rockland Immunochemicals Inc., Promab Biotechnologies, Inc., Proteogenix, Innovagen Ab.

Custom Antibody Market, by Service:

Antibody Development
- Antibody Characterization
- Antigen Preparation
- Immunization & Hybridoma Production

Antibody Production & Purification

Antibody Fragmentation & Labeling

Custom Antibody Market, by Source:

Mice

Rabbits

Human Beings

Others

Custom Antibody Market, by Type:

Monoclonal Antibodies

Polyclonal Antibodies

Recombinant Antibodies

Other Custom Antibodies

Custom Antibody Market, by Research Area:

Oncology

Infectious Diseases

Immunology

Neurobiology

Stem Cells

Cardiovascular Diseases

Others

Custom Antibody Market, by End-Users:

Hospitals and Clinics

Pharmaceutical & Biotechnology Companies

Academic & Research Institutes

Contract Research Organizations

Custom Antibody Market, by Region:

Americas
- North America
  - US
  - Canada
- South America

Europe
- Western Europe
  - Germany
  - France
  - Italy
  - Spain
  - UK
  - Rest of Western Europe
- Eastern Europe

Asia-Pacific
- Japan
- China
- India
- Australia
- South Korea
- Rest of Asia-Pacific

Middle East & Africa
- Middle East
- Africa

Company Profiles:

Thermo Fisher Scientific Inc.

Genscript

Abcam PLC

Merck Group

Bio-Rad Laboratories, Inc.

Cell Signaling Technology, Inc.

Agilent Technologies, Inc.

Biolegend, Inc.

Rockland Immunochemicals Inc.

Promab Biotechnologies, Inc.

Proteogenix

Innovagen Ab

Intended Audience:

Manufacturers and distributors

Healthcare institutions (hospitals, laboratories, medical schools, and outpatient clinics)

Research institutes

Contract manufacturing organizations (CMOs)

Government associations

Market research and consulting firms

Venture capitalists and investors

Report Scope:

Report Attribute/Metric	Details
Market Size	2027: Significant Value
CAGR	9.6% (2018-2023)
Base Year	2019
Forecast Period	2020-2027
Historical Data	2018
Forecast Units	Value (USD Million)
Report Coverage	Revenue Forecast, Competitive Landscape, Growth Factors, and Trends
Segments Covered	Service, Source, Type, Research area and End users
Geographies Covered	North America, Europe, Asia-Pacific, and Rest of the World (RoW)
Key Vendors	Thermo Fisher Scientific Inc., Genscript, Abcam PLC, Merck Group, Bio-Rad Laboratories, Inc., Cell Signaling Technology, Inc., Agilent Technologies, Inc., Biolegend, Inc., Rockland Immunochemicals Inc., Promab Biotechnologies, Inc., Proteogenix, Innovagen Ab
Key Market Opportunities	New product launches and R&D Amongst major key Players
Key Market Drivers	Increasing research activity in life sciences industry Increasing associations between industry and academic centers

Speak to Analyst Ask for Customization

Table of Contents:

Chapter 1. Report Prologue

Chapter 2. Market Introduction

2.1 Definition

2.2 Scope of the Study

2.2.1 Research Objective

2.2.2 Assumptions

2.2.3 Limitations

Chapter 3. Research Methodology

3.1 Introduction

3.2 Primary Research

3.3 Secondary Research

3.4 Market Size Estimation

Chapter 4. Market Dynamics

4.1 Drivers

4.2 Restraints

4.3 Opportunities

4.4 Challenges

4.5 Macroeconomic Indicators

4.6 Technology Trends & Assessment

Chapter 5. Market Factor Analysis

5.1 Porter’s Five Forces Analysis

5.1.1 Bargaining Power of Suppliers

5.1.2 Bargaining Power of Buyers

5.1.3 Threat of New Entrants

5.1.4 Threat of Substitutes

5.1.5 Intensity of Rivalry

5.2 Value Chain Analysis

5.3 Investment Feasibility Analysis

5.4 Pricing Analysis

Chapter 6. Global Custom Antibody Market, by Service

6.1 Introduction

6.2 Antibody Development

6.2.1 Antibody Characterization

Market Estimates & Forecast, by Region, 2020-2027